| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.9 |